Yale University
耶鲁大学
elsewhere's corpus does not cover Yale University as a subject. The only mentions in the retrieved material are passing references: one to a Yale-affiliated researcher, Priyadarshini Panda, in an Oasis Capital interview with Professor Yuan Li on neuromorphic computing , and another to a "Yale senior" who collaborated with Stanford's Zhao Xuan on visual and social cognition research during Zhao's undergraduate years at Zhejiang University . These name-drops appear in articles about other people and topics, not about Yale itself.
AI-generated — may contain errors, please verify.
Coverage
Tiangong Kaiwu: The Fifth Paradigm
A Material, An Industry
Undercover Inside Cursor for 60 Days
We rarely translate articles from foreign publications. But this one, we had to share.
Trying, Listening to Your Inner Voice, Building Irreplaceability — Talking Opportunities and Choices in the AI Era with Four Gen Z Young People
No one can become someone else; they can only become themselves.
The "Pinduoduo" of M&A: A New Model of Entrepreneurship Built for Investors | Entering the Game
It was a hit in the US for three decades, but remains niche in China.
Floodgate founding partner Mike Maples' year-opening podcast: How to invest in the next 100x startup
Every great startup exists to build a future that is destined to arrive.
Stanford University's Zhao Xuan: Psychological Healing Agent | Agent Insights
Counselor Vitality
A Conversation with Adam Tooze: How Venture Capital Reached Its Present Moment Through the Eyes of a Macroeconomist
Crises in this era tend to compound, yet remedies remain scarce.
Oasis Capital in Conversation with Professor Yuan Li: Preserving the Spark Before the Next Transformation
The Long-Termism of Transformation
"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
How Does the Fusion of Science and Art Spark Creativity? | 5Y View
Every artist is busy questioning and studying the world, just like a scientist.
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
The Collision of AI and Pharmaceuticals: Galaxy Pharma Tech Raises Nearly $10 Million in Funding | Light Moments
Galixir announced the completion of a nearly $10 million Pre-A funding round. The round was co-led by Source Code Capital and DCM, with 5Y Capital participating as a follow-on investor. Gaorong Capital, the lead investor in the company's angel round, continued to increase its stake.
